收费全文 | 43656篇 |
免费 | 2609篇 |
国内免费 | 203篇 |
耳鼻咽喉 | 406篇 |
儿科学 | 1257篇 |
妇产科学 | 1089篇 |
基础医学 | 6215篇 |
口腔科学 | 952篇 |
临床医学 | 3986篇 |
内科学 | 8826篇 |
皮肤病学 | 1173篇 |
神经病学 | 3892篇 |
特种医学 | 1359篇 |
外科学 | 5304篇 |
综合类 | 292篇 |
现状与发展 | 1篇 |
一般理论 | 31篇 |
预防医学 | 3971篇 |
眼科学 | 1119篇 |
药学 | 3001篇 |
中国医学 | 207篇 |
肿瘤学 | 3387篇 |
2023年 | 274篇 |
2022年 | 578篇 |
2021年 | 1092篇 |
2020年 | 652篇 |
2019年 | 930篇 |
2018年 | 1191篇 |
2017年 | 884篇 |
2016年 | 1015篇 |
2015年 | 1223篇 |
2014年 | 1578篇 |
2013年 | 1989篇 |
2012年 | 3318篇 |
2011年 | 3419篇 |
2010年 | 1757篇 |
2009年 | 1469篇 |
2008年 | 2979篇 |
2007年 | 2957篇 |
2006年 | 2785篇 |
2005年 | 2780篇 |
2004年 | 2503篇 |
2003年 | 2337篇 |
2002年 | 2080篇 |
2001年 | 1070篇 |
2000年 | 1074篇 |
1999年 | 695篇 |
1998年 | 344篇 |
1997年 | 267篇 |
1996年 | 243篇 |
1995年 | 206篇 |
1994年 | 173篇 |
1993年 | 154篇 |
1992年 | 201篇 |
1991年 | 194篇 |
1990年 | 165篇 |
1989年 | 123篇 |
1988年 | 105篇 |
1987年 | 117篇 |
1986年 | 105篇 |
1985年 | 112篇 |
1984年 | 92篇 |
1983年 | 79篇 |
1982年 | 92篇 |
1981年 | 74篇 |
1980年 | 71篇 |
1979年 | 71篇 |
1977年 | 61篇 |
1976年 | 56篇 |
1975年 | 53篇 |
1974年 | 69篇 |
1973年 | 60篇 |
Background
Routine measurement of Patient Reported Outcomes (PROs) linked with clinical data across the patient pathway is increasingly important for informing future care planning. The innovative electronic Patient-reported Outcomes from Cancer Survivors (ePOCS) system was developed to integrate PROs, collected online at specified post-diagnostic time-points, with clinical and treatment data in cancer registries.Objective
This study tested the technical and clinical feasibility of ePOCS by running the system with a sample of potentially curable breast, colorectal, and prostate cancer patients in their first 15 months post diagnosis.Methods
Patients completed questionnaires comprising multiple Patient Reported Outcome Measures (PROMs) via ePOCS within 6 months (T1), and at 9 (T2) and 15 (T3) months, post diagnosis. Feasibility outcomes included system informatics performance, patient recruitment, retention, representativeness and questionnaire completion (response rate), patient feedback, and administration burden involved in running the system.Results
ePOCS ran efficiently with few technical problems. Patient participation was 55.21% (636/1152) overall, although varied by approach mode, and was considerably higher among patients approached face-to-face (61.4%, 490/798) than by telephone (48.8%, 21/43) or letter (41.0%, 125/305). Older and less affluent patients were less likely to join (both P<.001). Most non-consenters (71.1%, 234/329) cited information technology reasons (ie, difficulty using a computer). Questionnaires were fully or partially completed by 85.1% (541/636) of invited participants at T1 (80 questions total), 70.0% (442/631) at T2 (102-108 questions), and 66.3% (414/624) at T3 (148-154 questions), and fully completed at all three time-points by 57.6% (344/597) of participants. Reminders (mainly via email) effectively prompted responses. The PROs were successfully linked with cancer registry data for 100% of patients (N=636). Participant feedback was encouraging and positive, with most patients reporting that they found ePOCS easy to use and that, if asked, they would continue using the system long-term (86.2%, 361/419). ePOCS was not administratively burdensome to run day-to-day, and patient-initiated inquiries averaged just 11 inquiries per month.Conclusions
The informatics underlying the ePOCS system demonstrated successful proof-of-concept – the system successfully linked PROs with registry data for 100% of the patients. The majority of patients were keen to engage. Participation rates are likely to improve as the Internet becomes more universally adopted. ePOCS can help overcome the challenges of routinely collecting PROs and linking with clinical data, which is integral for treatment and supportive care planning and for targeting service provision. 相似文献The aim of this study was to investigate in vitro the effect of clodronate on interleukin-1ß (IL-1ß)–stimulated human periodontal ligament fibroblasts (HPdLFs) with the focus on inflammatory factors of orthodontic tooth movement with and without compressive force.
Materials and methodsHPdLFs were incubated with 5 μM clodronate and 10 ng/mL IL-1ß. After 48 h, cells were exposed to 3 h of compressive force using a centrifuge. The gene expression of cyclooxygenase-2 (COX-2), interleukin-6 (IL-6), matrix metalloproteinase 8 (MMP-8), and the tissue inhibitor of MMP (TIMP-1) was analyzed using RT-PCR. Prostaglandin E2 (PGE-2), IL-6, and TIMP-1 protein syntheses were quantified via ELISA.
ResultsCompressive force and IL-1ß induced an overexpression of COX-2 gene expression (61.8-fold; p < 0.05 compared with control), diminished by clodronate (41.1-fold; p < 0.05 compared with control). Clodronate slowed down the compression and IL-1ß induced IL-6 gene expression (161-fold vs. 85.6-fold; p < 0.05 compared with control). TNF-α was only slightly affected without statistical significance. Clodronate reduced IL-1ß-stimulated MMP-8 expression with and without compressive force. TIMP-1 on gene and protein level was downregulated in all groups. Analyzing the MMP-8/TIMP-1 ratio, the highest ratio was detected in IL-1ß-stimulated HPdLFs with compressive force (21.2-fold; p < 0.05 compared with control). Clodronate diminished IL-1ß-induced upregulation of MMP-8/TIMP-1 ratio with (11.5-fold; p < 0.05 compared with control) and without (12.5-fold; p < 0.05 compared with control) compressive force.
ConclusionOur study demonstrates a slightly anti-inflammatory effect by clodronate under compressive force in vitro. Additionally, the periodontal remodeling presented by the MMP-8/TIMP-1 ratio seems to be diminished by clodronate.
Clinical relevanceReduction of pro-inflammatory factors and reduction of periodontal remodeling might explain reduced orthodontic tooth movement under clodronate intake.
相似文献